Alternatives to death: understanding androgen-independent prostate cancer

Perceptual learning after test-stimulus exposure in humans.

Behavioural processes·2019

DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.

Oncogene·2017

A system for detecting high impact-low frequency mutations in primary tumors and metastases.

Oncogene·2017

EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.

Oncogene·2016

Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.

Oncogene·2013

Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer.

Prostate cancer and prostatic diseases·2013

A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.

Nature medicine·2026

COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer.

Nature medicine·2026

Phenomic profiles and disease patterns of 1.9 million participants from Our Future Health.

Nature medicine·2026

Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.

Nature medicine·2026

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial.

Nature medicine·2026

Integrative Analysis of IGFL2‑AS1 and BRCA1 Expression in Esophageal Cancer: An Experimental and Bioinformatics‑Based Study.

Iranian biomedical journal·2026

Vesicocutaneous fistula secondary to invasive bladder squamous cell carcinoma: an unusual initial presentation.

BMJ case reports·2026

SMC1A drives radioresistance in lung squamous cell carcinoma through the ILF2/RNF2 axis.

Biochimica et biophysica acta. Molecular basis of disease·2026

The fear in the waiting room.

Med (New York, N.Y.)·2026

Dual-Targeted Inhibition of PAR2 Endosomal Signaling in Synoviocytes and Nociceptors Attenuates Osteoarthritis Pain.

Nanomaterials (Basel, Switzerland)·2026

Related Experiment Videos

Alternatives to death: understanding androgen-independent prostate cancer

Related Concept Videos

Perceptual learning after test-stimulus exposure in humans.

DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.

A system for detecting high impact-low frequency mutations in primary tumors and metastases.

EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.

Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.

Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer.

A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.

COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer.

Phenomic profiles and disease patterns of 1.9 million participants from Our Future Health.

Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial.

Integrative Analysis of IGFL2‑AS1 and BRCA1 Expression in Esophageal Cancer: An Experimental and Bioinformatics‑Based Study.

Vesicocutaneous fistula secondary to invasive bladder squamous cell carcinoma: an unusual initial presentation.

SMC1A drives radioresistance in lung squamous cell carcinoma through the ILF2/RNF2 axis.

The fear in the waiting room.

Dual-Targeted Inhibition of PAR2 Endosomal Signaling in Synoviocytes and Nociceptors Attenuates Osteoarthritis Pain.

Related Experiment Videos

Alternatives to death: understanding androgen-independent prostate cancer

Related Concept Videos

Related Articles